Deferred Tax Assets, Valuation Allowance of OptimizeRx Corp from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
OptimizeRx Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • OptimizeRx Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $1,900,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

OptimizeRx Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,900,000 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,900,000 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,900,000 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $4,220,000 +$864,000 +26% 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q4 2023 $3,356,000 -$4,806,000 -59% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $8,162,000 +$2,900,000 +55% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q4 2021 $5,262,000 +$3,005,000 +133% 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q4 2020 $2,257,000 +$529,000 +31% 31 Dec 2020 10-K/A 10 Mar 2023 2021 FY
Q4 2019 $1,728,000 -$1,210,000 -41% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q4 2018 $2,938,000 -$83,000 -2.7% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q4 2017 $3,021,000 -$1,165,000 -28% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $4,186,000 +$1,076,000 +35% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q4 2015 $3,110,000 -$16,000 -0.51% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q4 2014 $3,126,000 +$333,000 +12% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q1 2014 $4,996,000 +$9,738,000 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $2,793,000 +$7,531,000 31 Dec 2013 10-K 16 Sep 2015 2014 FY
Q3 2013 $4,618,000 +$129,000 +2.7% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 $4,622,000 +$89,000 +1.9% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 $4,742,000 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 $4,738,000 -$155,000 -3.4% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $4,747,000 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $4,711,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q4 2011 $4,583,000 31 Dec 2011 10-K 12 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.